SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    T.-C. Tseng, J.-H. Kao, Treating Immune-tolerant Hepatitis B, Journal of Viral Hepatitis, 2015, 22, 1
  2. 2
    Christian Trépo, Henry L Y Chan, Anna Lok, Hepatitis B virus infection, The Lancet, 2014, 384, 9959, 2053

    CrossRef

  3. 3
    Yi-Cheng Chen, Yun-Fan Liaw, Immunotolerant HBeAg Positive Patients: To Treat or Not to Treat, Current Hepatology Reports, 2014, 13, 3, 245

    CrossRef

  4. 4
    Stuart C. Gordon, Zahary Krastev, Andrzej Horban, Jörg Petersen, Jan Sperl, Phillip Dinh, Eduardo B. Martins, Leland J. Yee, John F. Flaherty, Kathryn M. Kitrinos, Vinod K. Rustgi, Patrick Marcellin, Efficacy of tenofovir disoproxil fumarate at 240 weeks in patients with chronic hepatitis B with high baseline viral load, Hepatology, 2013, 58, 2
  5. 5
    Xiao-Jun Zhu, Xue-Hua Sun, Zheng-Hua Zhou, Shun-Qing Liu, Hua Lv, Man Li, Lu Li, Yue-Qiu Gao, Lingmao Formula Combined with Entecavir for HBeAg-Positive Chronic Hepatitis B Patients with Mildly Elevated Alanine Aminotransferase: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial, Evidence-Based Complementary and Alternative Medicine, 2013, 2013, 1

    CrossRef

  6. 6
    Steven J. Scaglione, Anna S.F. Lok, Effectiveness of Hepatitis B Treatment in Clinical Practice, Gastroenterology, 2012, 142, 6, 1360

    CrossRef

  7. 7
    Jia-Feng Wu, Yu-Ru Su, Chen-Hsin Chen, Huey-Ling Chen, Yen-Hsuan Ni, Hong-Yuan Hsu, Jane-Ling Wang, Mei-Hwei Chang, Predictive Effect of Serial Serum Alanine Aminotransferase Levels on Spontaneous HBeAg Seroconversion in Chronic Genotype B and C HBV–Infected Children, Journal of Pediatric Gastroenterology and Nutrition, 2012, 54, 1, 97

    CrossRef

  8. 8
    Vincent Wai-Sun Wong, Grace Lai-Hung Wong, Karen Kar-Lum Yiu, Angel Mei-Ling Chim, Shirley Ho-Ting Chu, Hoi-Yun Chan, Joseph Jao-Yiu Sung, Henry Lik-Yuen Chan, Entecavir treatment in patients with severe acute exacerbation of chronic hepatitis B, Journal of Hepatology, 2011, 54, 2, 236

    CrossRef

  9. 9
    Tony Andreani, HBV-carriers: When is monitoring and surveillance sufficient? (point of view), Clinics and Research in Hepatology and Gastroenterology, 2011, 35, 12, 813

    CrossRef

  10. 10
    Hellan Kwon, Anna S. Lok, Hepatitis B therapy, Nature Reviews Gastroenterology & Hepatology, 2011,

    CrossRef

  11. 11
    Jurriën G.P. Reijnders, Vincent Rijckborst, Milan J. Sonneveld, Sandra M.J. Scherbeijn, Charles A.B. Boucher, Bettina E. Hansen, Harry L.A. Janssen, Kinetics of hepatitis B surface antigen differ between treatment with peginterferon and entecavir, Journal of Hepatology, 2011, 54, 3, 449

    CrossRef

  12. 12
    Ellen Sloth Andersen, Ola Weiland, Peter Leutscher, Henrik Krarup, Johan Westin, Belinda Moessner, Zbigniew Konopski, Svein-Oskar Frigstad, Mette Kjær, Peer Brehm Christensen, Nina Weis, Low liver stiffness among cirrhotic patients with hepatitis B after prolonged treatment with nucleoside analogs, Scandinavian Journal of Gastroenterology, 2011, 46, 6, 760

    CrossRef

  13. 13
    Syed-Mohammed R. Jafri, Anna Suk-Fong Lok, Antiviral Therapy for Chronic Hepatitis B, Clinics in Liver Disease, 2010, 14, 3, 425

    CrossRef

  14. 14
    Anna S. F. Lok, Drug Therapy: Tenofovir, Hepatology, 2010, 52, 2
  15. 15
    Chanunta Hongthanakorn, Anna S.F. Lok, New Pharmacologic Therapies in Chronic Hepatitis B, Gastroenterology Clinics of North America, 2010, 39, 3, 659

    CrossRef

  16. 16
    Anna S. Lok, Should antiviral treatment be extended to patients with chronic hepatitis B and mildly elevated alanine aminotransferase?, Hepatology, 2010, 51, 4
  17. 17
    Anna S. F. Lok, Francesco Negro, Hepatitis B and D,
  18. 18
    Hellan K. Kwon, Anna S.F. Lok, Treatment of Hepatitis B,